Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-21 4:45 pm Unchanged |
2021-06-11 | 13G | NVN LIQUIDATION, INC. NOVNQ |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-06-16 5:20 pm Purchase |
2021-06-15 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 8,670,644 20.800% |
8,670,644 (New Position) |
Filing History |
| 2021-06-16 4:59 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,291,881 15.600% |
4,291,881 (New Position) |
Filing History |
| 2021-06-15 4:32 pm Purchase |
2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS |
RA Capital Management, L.P. | 957,624 7.500% |
957,624 (New Position) |
Filing History |
| 2021-06-07 5:12 pm Purchase |
2021-06-04 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 6,991,003 12.200% |
350,586 (+5.28%) |
Filing History |
| 2021-06-07 4:48 pm Purchase |
2021-05-27 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 4,965,588 8.000% |
4,965,588 (New Position) |
Filing History |
| 2021-06-04 4:32 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,965,769 24.800% |
229,555 (+4.85%) |
Filing History |
| 2021-05-27 4:44 pm Purchase |
2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 1,399,489 5.700% |
613,219 (+77.99%) |
Filing History |
| 2021-05-17 4:35 pm Sale |
2021-05-17 | 13G | PANDION THERAPEUTICS INC PAND |
RA Capital Management, L.P. | 0 0.000% |
-1,770,023 (Position Closed) |
Filing History |
| 2021-05-17 4:34 pm Sale |
2021-05-17 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RA Capital Management, L.P. | 0 0.000% |
-4,285,161 (Position Closed) |
Filing History |
| 2021-05-17 4:33 pm Sale |
2021-05-17 | 13G | Inhibrx Biosciences, Inc. INBX |
RA Capital Management, L.P. | 0 0.000% |
-2,129,003 (Position Closed) |
Filing History |
| 2021-05-17 4:32 pm Sale |
2021-05-17 | 13G | Lyra Therapeutics, Inc. LYRA |
RA Capital Management, L.P. | 0 0.000% |
-815,849 (Position Closed) |
Filing History |
| 2021-05-06 4:33 pm Purchase |
2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL |
RA Capital Management, L.P. | 3,968,583 14.400% |
3,968,583 (New Position) |
Filing History |
| 2021-05-05 4:39 pm Purchase |
2021-04-27 | 13G | Seres Therapeutics, Inc. MCRB |
RA Capital Management, L.P. | 4,702,206 5.100% |
4,702,206 (New Position) |
Filing History |
| 2021-04-16 4:34 pm Purchase |
2021-04-06 | 13D | Achilles Therapeutics plc ACHL |
RA Capital Management, L.P. | 5,014,687 12.340% |
5,014,687 (New Position) |
Filing History |
| 2021-04-07 4:32 pm Unchanged |
2020-04-01 | 13G | Trillium Therapeutics Inc. TRIL |
RA Capital Management, L.P. | 5,290,481 5.100% |
0 (Unchanged) |
Filing History |
| 2021-04-07 4:31 pm Unchanged |
2021-04-01 | 13G | Atea Pharmaceuticals, Inc. AVIR |
RA Capital Management, L.P. | 5,368,451 6.500% |
0 (Unchanged) |
Filing History |
| 2021-04-07 4:30 pm Purchase |
2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT |
RA Capital Management, L.P. | 2,378,325 6.500% |
2,378,325 (New Position) |
Filing History |
| 2021-03-30 4:43 pm Purchase |
2021-03-24 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 3,865,808 7.530% |
155,109 (+4.18%) |
Filing History |
| 2021-03-29 4:30 pm Purchase |
2021-03-19 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 6,640,417 11.500% |
6,640,417 (New Position) |
Filing History |